Clinical trial
Edotecarin and Cisplatin in Treating Patients With Advanced or Metastatic Solid…
NCT00072332 · Memorial Sloan Kettering Cancer Center, Other · Completed
Key facts
| NCT number | NCT00072332 |
|---|---|
| Title | Edotecarin and Cisplatin in Treating Patients With Advanced or Metastatic Solid Tumors |
| Official title | A Phase I Dose Escalation Study of Edotecarin (PHA-782615) and Cisplatin in Adult Patients With Advanced/Metastatic Solid Tumors |
| Lead sponsor | Memorial Sloan Kettering Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Esophageal Cancer, Gastric Cancer, Unspecified Adult Solid Tumor, Protocol Specific |
| Intervention type | Drug |
| Interventions | cisplatin, edotecarin |
| Start date | Aug 1, 2003 |
| Primary completion | Dec 1, 2005 |
| Completion | Dec 1, 2009 |
| First posted | Nov 6, 2003 |
| Last update posted | Dec 19, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: